Complete response to second line paclitaxel every 2 weeks of eyelid kaposi sarcoma: A case report

Anna Elisabetta Brunetti, Attilio Guarini, Vito Lorusso, Carla Minoia, Angela Sabatelli, Ilaria Marech, Nicola Silvestris

Research output: Contribution to journalArticlepeer-review

Abstract

A 77-year-old male patient presented to our attention with violaceous nodular lesions on the skin of his hands and lower extremities. Clinical and histologic examination supported the diagnosis of Kaposi sarcoma. A first-line systemic chemotherapy based on liposomal doxorubicin at a dosage of 40 mg/mevery 3 weeks for 5 cycles was carried out, resulting in partial resolution of skin lesions. However, 1 year later, a relapse of the disease in the lower limbs and a new lesion of the left eyelid were found, therefore the patient began a second-line therapy with 100 mg/mpaclitaxel every 2 weeks. After 8 cycles of therapy, we observed a complete remission of eyelid tumor and a partial response of lower limbs lesions up to 6 months of follow up. In conclusion, eyelid Kaposi sarcoma was successfully treated with paclitaxel every 2 weeks, obtaining a complete response.

Original languageEnglish
JournalOphthalmic Plastic and Reconstructive Surgery
Volume29
Issue number5
DOIs
Publication statusPublished - Sep 2013

ASJC Scopus subject areas

  • Ophthalmology
  • Surgery

Fingerprint Dive into the research topics of 'Complete response to second line paclitaxel every 2 weeks of eyelid kaposi sarcoma: A case report'. Together they form a unique fingerprint.

Cite this